Dr.Reddy’s acquires JB Chemicals business in Russia
July 23rd, 2011 - 12:15 am ICT by IANSHyderabad, July 22 (IANS) Dr.Reddy’s Laboratories Friday announced it has entered into an agreement with JB Chemicals and Pharmaceuticals to acquire its pharmaceutical prescription portfolio in Russia and other CIS regions for Rs. 1.5 billion ($34.85 million).
The agreement involves acquisition of 20 brands, key ones being Metrogyl and Jocet. Dr. Reddy’s has also entered into a supply agreement with JB Chemicals for the continued manufacturing and supply of these products associated with the acquired brands, said a statement by the pharma major.
“Russia is one of our leading markets where we enjoy a strong equity with stakeholders. This acquisition will help expand our prescription, hospital and OTC portfolio, complement our existing strong basket of products and add to our growth aspirations in the Russia and other CIS region,” said Satish Reddy, managing director and COO of Dr. Reddy’s.
Dr. Reddy’s is the largest Indian pharmaceutical company in Russia and also the fastest growing international branded generic company by volume.
The company revenue from Russia and other CIS markets during 2010-11 was Rs.10.9 bn ($244 mn), representing a growth of 19 percent.
- Surya Pharma's arm acquires US's ActivOn for $22 mn - Dec 28, 2010
- Dr Reddy's acquires US-based oral penicillin facility - Nov 24, 2010
- Goose launches Artwork Manager for pharma industry - Jan 03, 2012
- Hotel group to open 100 hotels in Russia, CIS - Sep 12, 2011
- Dr. Reddy's buys BASF manufacturing unit in US - Apr 30, 2008
- Capitol One to acquire HSBC's domestic credit card business for $2.6 billion - Aug 10, 2011
- Pfizer to acquire King Pharmaceuticals for $3.6 billion in cash - Oct 12, 2010
- Titan to acquire Swiss brand for Rs.13.6 crore - Nov 16, 2011
- Parkway stake makes Fortis largest Asian hospital chain - Mar 12, 2010
- Belkin to increase Indian channel partners to 30,000 - Dec 06, 2011
- Automatic approval to FDI in greenfield pharma projects to continue: RBI - Dec 12, 2011
- Sweet deal: EID Parry acquires balance stake in US firm - Oct 07, 2011
- Reckitt Benckiser to acquire Paras Pharma for $728 mn - Dec 13, 2010
- Jubilant inks $80 mn contract with global firm - Aug 12, 2011
- Orchid Chemical to acquire US marketing company - Jun 10, 2010
Tags: acquisition, aspirations, business in russia, chemicals business, cis markets, cis region, coo, dr reddy, generic company, hyderabad, indian pharmaceutical company, jb chemicals, managing director, metrogyl, otc, pharma, pharmaceuticals, rs 1